| | Identification | Back Directory |  | [Name] 
 Gomisin M2
 |  | [CAS] 
 82425-45-4
 |  | [Synonyms] 
 Gomisin M2
 (+)Gomisin M2
 Benzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-13-ol, 5,6,7,8-tetrahydro-1,2,3-trimethoxy-6,7-dimethyl-, (6S,7R,13aR)-
 |  | [EINECS(EC#)] 
 2017-001-1
 |  | [Molecular Formula] 
 C22H26O6
 |  | [MDL Number] 
 MFCD20260419
 |  | [MOL File] 
 82425-45-4.mol
 |  | [Molecular Weight] 
 386.44
 | 
 | Chemical Properties | Back Directory |  | [Boiling point ] 
 558.7±50.0 °C(Predicted)
 |  | [density ] 
 1.195±0.06 g/cm3(Predicted)
 |  | [storage temp. ] 
 4°C, protect from light
 |  | [solubility ] 
 Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
 |  | [form ] 
 Powder
 |  | [pka] 
 8.96±0.60(Predicted)
 |  | [color ] 
 White to yellow
 | 
 | Hazard Information | Back Directory |  | [Uses] 
 (+)-Gomisin M2 can be used as an active ingredient to prevent and treat various allergy related diseases, as well as, protect from hepatic injury.
 |  | [target] 
 HIV
 | 
 | 
                    
                        
                            | Company Name: | BioBioPha Co., Ltd. |  
                            | Tel: | 0871-65217109 13211707573; |  
                            | Website: | http://www.biobiopha.com |  |